Indications for red cell transfusion in sickle cell disease, Seminars in Hematology, vol.38, issue.1 1, pp.5-13, 2001. ,
DOI : 10.1016/S0037-1963(01)90055-1
Alloimmunization in Sickle Cell Anemia and Transfusion of Racially Unmatched Blood, New England Journal of Medicine, vol.322, issue.23, pp.1617-1638, 1990. ,
DOI : 10.1056/NEJM199006073222301
Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety, Blood, vol.100, issue.12, pp.4223-4254, 2002. ,
DOI : 10.1182/blood-2002-01-0229
Particularit??s immunoh??matologiques dans les populations africaines et antillaises. Implications transfusionnelles, Transfusion Clinique et Biologique, vol.10, issue.3, pp.185-91, 2003. ,
DOI : 10.1016/S1246-7820(03)00042-9
Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease, The American Journal of the Medical Sciences, vol.339, issue.3, pp.266-275, 2010. ,
DOI : 10.1097/MAJ.0b013e3181c70e14
Delayed haemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. Pediatrics, pp.111-661, 2003. ,
The sickle cell hemolytic transfusion reaction syndrome, Transfusion, vol.37, issue.4, pp.382-92, 1997. ,
DOI : 10.1046/j.1537-2995.1997.37497265338.x
Post-Transfusion Hyperhaemolysis in a Patient with Sickle Cell Disease: Use of Steroids and Intravenous Immunoglobulin to Prevent Further Red Cell Destruction, Vox Sanguinis, vol.67, issue.suppl, pp.355-362, 1995. ,
DOI : 10.1111/j.1423-0410.1995.tb00373.x
Hyperhemolytic transfusion reaction in sickle cell disease, Transfusion, vol.73, issue.3, pp.323-331, 2001. ,
DOI : 10.1054/blre.1999.0121
Risk of Alloimmunization and Delayed Hemolytic Transfusion Reactions in Patients With Sickle Cell Disease, Archives of Internal Medicine, vol.148, issue.11, pp.2485-2494, 1988. ,
DOI : 10.1001/archinte.1988.00380110115024
Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization, Transfusion, vol.49, issue.1, pp.13-22, 2010. ,
DOI : 10.1111/j.1537-2995.2009.02382.x
Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death, Transfusion, vol.2007, issue.9, pp.1785-92, 2009. ,
DOI : 10.1111/j.1537-2995.2009.02199.x
Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease, Haematologica, vol.92, issue.12, pp.132-135, 2007. ,
DOI : 10.3324/haematol.12074
Severe Neurologic Complication After Delayed Hemolytic Transfusion Reaction in 2 Children With Sickle Cell Anemia, Journal of Pediatric Hematology/Oncology, vol.30, issue.12, pp.928-958, 2008. ,
DOI : 10.1097/MPH.0b013e31818c9172
Rituximab as an effective treatment of hyperhemolysis syndrome in sickle cell anemia, American Journal of Hematology, vol.85, issue.1, pp.91-93, 2010. ,
DOI : 10.1002/ajh.21578
To RBC or not to RBC: the role of suicidal death in hemolytic transfusion reactions, Transfusion, vol.129, issue.1, pp.1776-1784, 2009. ,
DOI : 10.1111/j.1537-2995.2009.02339.x
Hydrolysis of Phosphatidylserine-exposing Red Blood Cells by Secretory Phospholipase A2 Generates Lysophosphatidic Acid and Results in Vascular Dysfunction, Journal of Biological Chemistry, vol.281, issue.2, pp.775-81, 2006. ,
DOI : 10.1074/jbc.M505790200
Hypothesis: hemolytic transfusion reactions represent an alternative type of anaphylaxis, Int J Clin Exp Pathol, vol.2, issue.1, pp.71-82, 2009. ,
Sickle cell anemia as an inflammatory disease, Journal of Clinical Investigation, vol.106, issue.3, pp.337-345, 2000. ,
DOI : 10.1172/JCI10726
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC314335
Cell Response to Surgery, Archives of Surgery, vol.141, issue.11, pp.1132-1172, 2006. ,
DOI : 10.1001/archsurg.141.11.1132
Treatment With Intravenous Immunoglobulin and Steroids May Correct Severe Anemia in Hyperhemolytic Transfusion Reactions: Case Report and Literature Review, Transfusion Medicine Reviews, vol.24, issue.1, pp.64-71, 2010. ,
DOI : 10.1016/j.tmrv.2009.09.006
Steroid treatment in children with sickle-cell disease, Haematologica, vol.92, issue.3, pp.425-431, 2007. ,
DOI : 10.3324/haematol.10800
The Mechanisms of Action of Intravenous Immunoglobulin and Polyclonal Anti-D Immunoglobulin in the Amelioration of Immune Thrombocytopenic Purpura: What Do We Really Know?, Transfusion Medicine Reviews, vol.22, issue.2, pp.103-119, 2008. ,
DOI : 10.1016/j.tmrv.2007.12.001
A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg?, Blood, vol.109, issue.1, pp.155-163, 2007. ,
DOI : 10.1182/blood-2006-05-023796
Anesthetics, immune cells, and immune responses, Journal of Anesthesia, vol.59, issue.1, pp.263-77, 2008. ,
DOI : 10.1007/s00540-008-0626-2